Point72 Asset Management
OMGA

Point72 Asset Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Point72 Asset Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-116,009
Closed -$86.5K – 2662
2024
Q4 		$86.5K Hold
116,009
– – ﹤0.01% 1975
2024
Q3 		$142K Hold
116,009
– – ﹤0.01% 1836
2024
Q2 		$240K Sell
116,009
-13,380
-10% -$31.5K ﹤0.01% 1582
2024
Q1 		$472K Hold
129,389
– – ﹤0.01% 1662
2023
Q4 		$389K Hold
129,389
– – ﹤0.01% 1645
2023
Q3 		$278K Hold
129,389
– – ﹤0.01% 1678
2023
Q2 		$725K Sell
129,389
-1,800
-1% -$14.1K ﹤0.01% 1186
2023
Q1 		$791K Buy
131,189
+1,800
+1% +$12.5K ﹤0.01% 1142
2022
Q4 		$739K Hold
129,389
– – ﹤0.01% 1093
2022
Q3 		$701K Hold
129,389
– – ﹤0.01% 1118
2022
Q2 		$492K Hold
129,389
– – ﹤0.01% 1184
2022
Q1 		$807K Hold
129,389
– – ﹤0.01% 984
2021
Q4 		$1.47M Sell
129,389
-91,749
-41% -$1.74M 0.01% 862
2021
Q3 		$4.17M Buy
+221,138
New +$4.24M 0.02% 692

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Point72 Asset Management's OMGA Position: Q1 2025 in Review

Point72 Asset Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 116,009 shares — an estimated $86.5K sold.

Point72 Asset Management first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $4.17M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Point72 Asset Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 116,009 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $86.5K.
  • Point72 Asset Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Point72 Asset Management's Omega Therapeutics, Inc. Common Stock position peaked at $4.17M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.